GNTA
Genenta Science S.p.A.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 10/2/2026 | View on SEC |
| 6-K | 9/11/2026 | View on SEC |
| 6-K | 9/2/2026 | View on SEC |
| 6-K | 7/31/2026 | View on SEC |
| 6-K | 7/14/2026 | View on SEC |
| 6-K | 7/1/2026 | View on SEC |
| 6-K | 6/26/2026 | View on SEC |
| 6-K | 6/24/2026 | View on SEC |
| 6-K | 6/17/2026 | View on SEC |
| 6-K | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GNTA |
| Company Name | Genenta Science S.p.A. |
| CIK | 1838716 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| State of Incorporation | L6 |
| Phone | 39-02-2643-6639 |